Organ donation programs could offer reimbursements under new bill

New legislation introduced in Congress aims to address a shortage of organs for transplants by changing or clarifying 32-year-old rules on what incentives can be offered to living organ donors.

The bill sponsored by Rep. Matt Cartwright, R-Pa., would address the portion of the 1984 National Organ Transplant Act (NOTA), which bans buying or selling organs for “valuable consideration.”

“Confusion about what constitutes valuable consideration has hampered donation by scaring people away from reimbursing living organ donors for things like medical expenses and lost wages,” Cartwright said in a statement.  “Both are legal under NOTA, but the law’s lack of clarity and its criminal penalties have created uncertainty and prevented reimbursements in many cases.”

The legislation would clarify that reimbursing a living donor for expenses related to donating an organlike travel, lost wages, follow-up care, paperwork or legal costs, or the effects on an insurance policywouldn’t fall under the “valuable consideration” definition in the 1984 law.

The proposal also allows for government-run pilot programs to test out the effectiveness of offering non-cash incentives to encourage organ donation.

“You make it something like a pension contribution or an education fund contribution, something that is not transferable,” Cartwright said in an ABC News interview.  

Programs would have to approved by HHS, distribute organs through existing channels, and last no longer than five years.

Those elements of the proposals are opposed by the National Kidney Foundation, which argued the language in the bill is too vague as to what a non-cash benefit could be.

“The Organ Donation Clarification Act of 2016, as written, leaves too much open for misinterpretation and could have the unintended consequence of doing harm to both the donor, and transplant recipient, alike,” the foundation said in a statement.

Cartwright’s office said the legislation is supported by other groups, including the American Medical Association and the American Foundation for Donation and Transplantation.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”